DHQZ-36 is a novel and potent small molecule retrograde trafficking inhibitor which is able to block infection by several human and monkey polyomaviruses. It acts by protecting cells from infections by human polyoma- and papillomaviruses. DHQZ-3 represents an advance in the development of drug candidates that can broadly protect humans from non-enveloped DNA viruses and toxins that exploit retrograde trafficking as a means for cell entry. Human polyoma- and papillomaviruses are non-enveloped DNA viruses that cause severe pathologies and mortalities. Under circumstances of immunosuppression, JC polyomavirus causes a fatal demyelinating disease called progressive multifocal leukoencephalopathy (PML) and the BK polyomavirus is the etiological agent of polyomavirus-induced nephropathy and hemorrhagic cystitis. Human papillomavirus type 16, another non-enveloped DNA virus, is associated with the development of cancers in tissues like the uterine cervix and oropharynx. Currently, there are no approved drugs or vaccines to treat or prevent polyomavirus infections.
C, 65.61; H, 4.72; F, 9.88; N, 7.29; O, 4.16; S, 8.34
|Related CAS #||
DHQZ-36; DHQZ 36; DHQZ36;
|HS Tariff Code||
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|Preparing Stock Solutions||1 mg||5 mg||10 mg|
|1 mM||2.6012 mL||13.0059 mL||26.0119 mL|
|5 mM||0.5202 mL||2.6012 mL||5.2024 mL|
|10 mM||0.2601 mL||1.3006 mL||2.6012 mL|
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
In vivo formula preparation method：take μL DMSO mother liquor，join μL Corn oil，mix well and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.